Series of case studies examining adverse events in diffuse large b-cell patients treated with CAR T therapy and PD-1 inhibitors.
Home / Resource Library / Immune Related Adverse Events Associated with Checkpoint Inhibition in the Setting of CAR T-Cell Therapy: A Case Series